CN108244323A - A kind of Inonotus obliquus pressed candy of energy anticancer reducing pressure and sugar prevention cerebral thrombus - Google Patents
A kind of Inonotus obliquus pressed candy of energy anticancer reducing pressure and sugar prevention cerebral thrombus Download PDFInfo
- Publication number
- CN108244323A CN108244323A CN201810288320.XA CN201810288320A CN108244323A CN 108244323 A CN108244323 A CN 108244323A CN 201810288320 A CN201810288320 A CN 201810288320A CN 108244323 A CN108244323 A CN 108244323A
- Authority
- CN
- China
- Prior art keywords
- parts
- inonotus obliquus
- pressed candy
- sugar
- cerebral thrombus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000414067 Inonotus obliquus Species 0.000 title claims abstract description 31
- 201000001429 Intracranial Thrombosis Diseases 0.000 title claims abstract description 13
- 230000001093 anti-cancer Effects 0.000 title claims abstract description 13
- 235000009508 confectionery Nutrition 0.000 title claims abstract description 12
- 230000002265 prevention Effects 0.000 title claims abstract description 10
- 241001264174 Cordyceps militaris Species 0.000 claims abstract description 11
- 241000208340 Araliaceae Species 0.000 claims abstract description 10
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 10
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 10
- 235000008434 ginseng Nutrition 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 239000004480 active ingredient Substances 0.000 claims abstract description 3
- 230000036772 blood pressure Effects 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 10
- 230000009471 action Effects 0.000 abstract description 6
- 230000002218 hypoglycaemic effect Effects 0.000 abstract description 5
- 230000036541 health Effects 0.000 abstract description 4
- 210000004185 liver Anatomy 0.000 abstract description 4
- 239000003963 antioxidant agent Substances 0.000 abstract description 3
- 230000003078 antioxidant effect Effects 0.000 abstract description 3
- 235000006708 antioxidants Nutrition 0.000 abstract description 3
- 230000002708 enhancing effect Effects 0.000 abstract description 3
- 235000013305 food Nutrition 0.000 abstract description 3
- 208000030507 AIDS Diseases 0.000 abstract description 2
- 230000036737 immune function Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 235000013361 beverage Nutrition 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 201000005202 lung cancer Diseases 0.000 description 4
- 208000020816 lung neoplasm Diseases 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 208000005718 Stomach Neoplasms Diseases 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 206010017758 gastric cancer Diseases 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 201000007270 liver cancer Diseases 0.000 description 3
- 208000014018 liver neoplasm Diseases 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 201000011549 stomach cancer Diseases 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- 241000747105 Fuscoporia Species 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 241000756042 Polygonatum Species 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 208000019065 cervical carcinoma Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000011278 mitosis Effects 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- BQPPJGMMIYJVBR-UHFFFAOYSA-N (10S)-3c-Acetoxy-4.4.10r.13c.14t-pentamethyl-17c-((R)-1.5-dimethyl-hexen-(4)-yl)-(5tH)-Delta8-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C BQPPJGMMIYJVBR-UHFFFAOYSA-N 0.000 description 1
- CHGIKSSZNBCNDW-UHFFFAOYSA-N (3beta,5alpha)-4,4-Dimethylcholesta-8,24-dien-3-ol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21 CHGIKSSZNBCNDW-UHFFFAOYSA-N 0.000 description 1
- XYTLYKGXLMKYMV-UHFFFAOYSA-N 14alpha-methylzymosterol Natural products CC12CCC(O)CC1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C XYTLYKGXLMKYMV-UHFFFAOYSA-N 0.000 description 1
- FPTJELQXIUUCEY-UHFFFAOYSA-N 3beta-Hydroxy-lanostan Natural products C1CC2C(C)(C)C(O)CCC2(C)C2C1C1(C)CCC(C(C)CCCC(C)C)C1(C)CC2 FPTJELQXIUUCEY-UHFFFAOYSA-N 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- KQLDDLUWUFBQHP-UHFFFAOYSA-N Cordycepin Natural products C1=NC=2C(N)=NC=NC=2N1C1OCC(CO)C1O KQLDDLUWUFBQHP-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000007241 Experimental Diabetes Mellitus Diseases 0.000 description 1
- BKLIAINBCQPSOV-UHFFFAOYSA-N Gluanol Natural products CC(C)CC=CC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(O)C(C)(C)C4CC3 BKLIAINBCQPSOV-UHFFFAOYSA-N 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- LOPKHWOTGJIQLC-UHFFFAOYSA-N Lanosterol Natural products CC(CCC=C(C)C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 LOPKHWOTGJIQLC-UHFFFAOYSA-N 0.000 description 1
- 206010027458 Metastases to lung Diseases 0.000 description 1
- CAHGCLMLTWQZNJ-UHFFFAOYSA-N Nerifoliol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C CAHGCLMLTWQZNJ-UHFFFAOYSA-N 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 241000037831 Polygonatum sibiricum Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 description 1
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- QBSJHOGDIUQWTH-UHFFFAOYSA-N dihydrolanosterol Natural products CC(C)CCCC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 QBSJHOGDIUQWTH-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 208000014829 head and neck neoplasm Diseases 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- CAHGCLMLTWQZNJ-RGEKOYMOSA-N lanosterol Chemical compound C([C@]12C)C[C@@H](O)C(C)(C)[C@H]1CCC1=C2CC[C@]2(C)[C@H]([C@H](CCC=C(C)C)C)CC[C@@]21C CAHGCLMLTWQZNJ-RGEKOYMOSA-N 0.000 description 1
- 229940058690 lanosterol Drugs 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 208000026037 malignant tumor of neck Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 230000031864 metaphase Effects 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000000394 mitotic effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 230000005195 poor health Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- -1 triterpene compound Chemical class 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The present invention relates to field of health care food, can anticancer reducing pressure and sugar prevention cerebral thrombus Inonotus obliquus pressed candy.Trade name is：Inonotus obliquus pressed candy.Its active ingredient is prepared from the following raw materials in parts by weight：30-35 parts of oligoisomaltose, 25-35 parts of Inonotus obliquus, 5-12 parts of spina date seed, 5-12 parts of sealwort, 5-12 parts of Cordyceps militaris, 4-6 parts of ginseng.Prescription is prepared simply, at low cost.Formula has edibility, has no toxic side effect, safe and reliable.There is booster action to anticancer, blood pressure lowering, hypoglycemic, anti-cerebral thrombus, anti-AIDS, radioresistance, anti-oxidant, calm, liver protection, enhancing immune function etc..
Description
Technical field
The present invention relates to field of health care food, can anticancer reducing pressure and sugar prevention cerebral thrombus Inonotus obliquus pressed candy.
Trade name is：Inonotus obliquus pressed candy.
Background technology
In the prior art, in recent years, solid beverage industry steps into fast-developing channel, enterprise inside the circle's quantity and row
Industry production and marketing scale constantly expands.Solid beverage because of numerous in variety, unique flavor, using plant extracts as primary raw material, be easy to deposit
It puts and receives consumers, especially those have nutrition, health-care assistance effect rich in vitamin, minerals, Chinese medicine etc.
Nutrition needed for body metabolism can be replenished in time in the solid beverage of ingredient, more become the good companion being be unable to do without during many life are lived
Companion.National publication integration of drinking and medicinal herbs article, solid beverage can add Chinese medicine, for making health food, meet the people day
The tonic of beneficial demand, solid beverage have welcome development opportunity.
Invention content
The object of the present invention is to provide a kind of prescription is simple, there is nutrition and health care, it is anticancer adjuvant, blood pressure lowering, hypoglycemic, anti-
The Inonotus obliquus pressed candy of cerebral thrombus effect.
The technical solution of the present invention：A kind of Inonotus obliquus pressed candy of energy anticancer reducing pressure and sugar prevention cerebral thrombus,
It is characterized in that its active ingredient is prepared from the following raw materials in parts by weight：30-35 parts of oligoisomaltose, Inonotus obliquus
25-35 parts, 5-12 parts of spina date seed, 5-12 parts of sealwort, 5-12 parts of Cordyceps militaris, 4-6 parts of ginseng.
It is preferably but not limited to：A kind of Inonotus obliquus pressed candy of energy anticancer reducing pressure and sugar prevention cerebral thrombus, feature exist
In being prepared from the following raw materials in parts by weight：35 parts of oligoisomaltose, 30 parts of Inonotus obliquus, 10 parts of spina date seed, 10 parts of sealwort,
10 parts of Cordyceps militaris, 5 parts of ginseng.
Preparation method：By Inonotus obliquus, spina date seed, sealwort, Cordyceps militaris, ginseng（Artificial growth）Through previous cleaning, extraction, baking
Oligoisomaltose allotment, granulation, tabletting are added in after dry, crushing, packaging is made.
The ingredient that main pharmacological is played in Inonotus obliquus is lanosterol type triterpenes, Inonotus obliquus alcohol, Inonotus obliquus
Element and lignin.With kinds of tumors such as resistance liver cancer, gastric cancer, lung cancer, cervical carcinoma, breast cancer, cutaneum carcinoma, the carcinoma of the rectum, lymphs
Cell and AIDS virus resisting, anti-infective, treatment diabetes, blood pressure lowering adjust blood fat, anti-body aging, strengthen immunity
Wait pharmacological actions.
Cordyceps militaris main component is ucleosides, polysaccharide, cordycepic acid, cordycepin, sterols, trace element and amino
Acid.Can promote thrombocytopoiesis, have anti-aging, it is anti-oxidant, improve hypoxia-bearing capability, be antifatigue and antitumor etc. multi-party
The pharmacological action in face.
The seed of spina date seed, that is, wild jujube, containing ingredients such as alkaloid, a variety of amino acid and metallic elements, can play it is calm,
Syngignoscism, stable effect, analgesia, cooling, cardiac effect, effect nourishing the liver, calming heart are calmed the nerves, arrest sweating.
HUANGJING ZANYU CAPSULE, rhizome it is horizontal walk, cylindric, tubercle expands.Impeller is given birth to, stockless.With tonifying spleen, the work of moistening lung and production of body fluid
With.Pharmacological action：Sealwort is excessively high to blood glucose caused by adrenaline present inhibiting effect, antifatigue effect, antioxidation,
Delaying senility function, to Cardiovascular, antivirus action.
Ginseng is herbaceos perennial.The fleshy root of ginseng is strong tonic, suitable for adjustment blood pressure, restores heart
Function, neurasthenia and the diseases such as in poor health, also there is eliminating the phlegm, stomach invigorating, diuresis, excitement and other effects.
Inonotus obliquus, Cordyceps militaris, three taste Chinese medicine of sealwort synergistic effect can enhance anti-aging, antitumor action in prescription,
Spina date seed, sealwort synergistic effect can enhance Cardiovascular, and ginseng can promote yang-energy as tonic, protect heart and brain blood
Pipe.
Dosage form of the present invention is without being limited thereto, may also be fabricated which that granule, powder, capsule or other field of health care food are routinely made
Agent.
Effect：Anticancer, decompression, hypoglycemic, anti-cerebral thrombus.
Usage and dosage：It is recommended that per consumption per day 6-10 pieces.
Target user：Blood pressure, high blood glucose, the sub-health population for enhancing immune function.
It is an advantage of the invention that：1. prescription is prepared simply, at low cost.2. formula have edibility, have no toxic side effect, safety, can
It leans on.3rd, it is immune to anticancer, blood pressure lowering, hypoglycemic, anti-cerebral thrombus, anti-AIDS, radioresistance, anti-oxidant, calm, liver protection, enhancing
Function etc. has booster action.4th, it is taken through 90 blood pressures of cumulative statistics, high blood glucose crowd, effective percentage 100%.
Embodiments of the present invention are described in further detail below in conjunction with embodiment.
Specific embodiment
Embodiment 1
A kind of Inonotus obliquus pressed candy of energy anticancer reducing pressure and sugar prevention cerebral thrombus, it is characterised in that by following parts by weight
Raw material is made：35 parts of oligoisomaltose, 30 parts of Inonotus obliquus, 10 parts of spina date seed, 10 parts of sealwort, 10 parts of Cordyceps militaris, ginseng 5
Part.
Test example
1. the experimental research achievements of pair Inonotus obliquus
Liver cancer, observation find Fuscoporia obliqua polysaccharide extract to liver cancer mouse HepA knurls inhibiting rate up to 39. 39 %；Gastric cancer, birch
Brown linteus extract has Inhibit proliferaton effect, inducing apoptosis of tumour cell to human gastric cancer BGC2823 cell strains, and shows
Dose-effect relationship；Lung cancer, influence of the observation Inonotus obliquus water decoction to patients with lung cancer intestinal flora, finds Inonotus obliquus group than simple
Bifidobacteria is significantly more in the enteron aisle of chemotherapy group, and coccus quantity is few；Cervical carcinoma, the water extract of Inonotus obliquus can make one palace
The protein quantity and mitotic index of neck cancer cell (HeLaS3) decline, and improve the cell number of mitosis metaphase, shadow
The cell cycle is rung, so as to which the mitosis of interference cell influences the metabolism of cell simultaneously；The observations such as other tumours, golden light
There are apparent inhibiting effect, the inhibition tumour rate of large and small dosage group to the growth of small S180 sarcoma of rats to Fuscoporia obliqua polysaccharide
Respectively 56. 31 % and 44. 34 %
The triterpene compound and steroids of Inonotus obliquus have the work for improving blood circulation, adjusting blood pressure, reducing cholesterolemia
With clinical observation to Inonotus obliquus has certain effect to prevention and treatment hypertension, can reduce the blood pressure of hypertensive patient simultaneously
Mitigate symptom, shared coordinative role with conventional buck medicine, made blood pressure more easy to control and steady.
Inonotus obliquus, inonotus obliquus sclerotium and mycelial polysaccharide crude extract, have drop to alloxan diabetes mouse
Blood glucose acts on, and without significant difference in three's hypoglycemic effect.
2. the experimental research achievements of pair Cordyceps militaris
Cordyceps militaris has inhibiting effect to mouse s180 and Lewis lung cancer, and Lung metastases are also reduced while tumour growth is delayed
The formation of rate.
3. the experimental research achievements of pair sealwort
Continuous 4 weeks of every gavage polygonatum oral liquid 0.2 of mouse, 0.4ml/d, swim 90min after put to death, with positive blank group pair
According to polygonatum oral liquid inhibits the heart, liver LPO generative capacities significantly to increase, and also in dose dependent, there is anti-aging to make for display
With.
It is described above, only specific embodiment of the invention, various illustrations are not to the substantive content structure of the present invention
Into limitation.
Claims (2)
1. it is a kind of can anticancer reducing pressure and sugar prevention cerebral thrombus Inonotus obliquus pressed candy, it is characterised in that its active ingredient by with
The raw material of lower parts by weight is made：30-35 parts of oligoisomaltose, 25-35 parts of Inonotus obliquus, 5-12 parts of spina date seed, sealwort
5-12 parts, 5-12 parts of Cordyceps militaris, 4-6 parts of ginseng.
2. the Inonotus obliquus pressed candy of energy anticancer reducing pressure and sugar prevention cerebral thrombus described in accordance with the claim 1, feature exist
In being prepared from the following raw materials in parts by weight：35 parts of oligoisomaltose, 30 parts of Inonotus obliquus, 10 parts of spina date seed, 10 parts of sealwort,
10 parts of Cordyceps militaris, 5 parts of ginseng.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810288320.XA CN108244323A (en) | 2018-03-30 | 2018-03-30 | A kind of Inonotus obliquus pressed candy of energy anticancer reducing pressure and sugar prevention cerebral thrombus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810288320.XA CN108244323A (en) | 2018-03-30 | 2018-03-30 | A kind of Inonotus obliquus pressed candy of energy anticancer reducing pressure and sugar prevention cerebral thrombus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108244323A true CN108244323A (en) | 2018-07-06 |
Family
ID=62748013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810288320.XA Pending CN108244323A (en) | 2018-03-30 | 2018-03-30 | A kind of Inonotus obliquus pressed candy of energy anticancer reducing pressure and sugar prevention cerebral thrombus |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108244323A (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102008516A (en) * | 2010-12-16 | 2011-04-13 | 刘振钦 | Ultrafine powder traditional Chinese medicine for treating tumors |
| CN102613547A (en) * | 2012-03-15 | 2012-08-01 | 黄宏植 | Diet therapy product capable of protecting heart and preparation method thereof |
| CN106070861A (en) * | 2016-06-06 | 2016-11-09 | 常立阁 | A kind of compound Inonqqus obliquus alternative tea and preparation method thereof |
| CN106421359A (en) * | 2016-08-30 | 2017-02-22 | 陈孝 | Medicine composition for comprehensively treating diabetes and complications thereof |
| CN106511442A (en) * | 2016-12-21 | 2017-03-22 | 河南爱因糖尿病健康科学研究院股份有限公司 | Inonotus obliquus compound tablet candy with function of reducing blood sugar and preparation method thereof |
| CN107114761A (en) * | 2017-06-13 | 2017-09-01 | 通化康元生物科技有限公司 | Inonotus obliquus ginseng sealwort piece |
-
2018
- 2018-03-30 CN CN201810288320.XA patent/CN108244323A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102008516A (en) * | 2010-12-16 | 2011-04-13 | 刘振钦 | Ultrafine powder traditional Chinese medicine for treating tumors |
| CN102613547A (en) * | 2012-03-15 | 2012-08-01 | 黄宏植 | Diet therapy product capable of protecting heart and preparation method thereof |
| CN106070861A (en) * | 2016-06-06 | 2016-11-09 | 常立阁 | A kind of compound Inonqqus obliquus alternative tea and preparation method thereof |
| CN106421359A (en) * | 2016-08-30 | 2017-02-22 | 陈孝 | Medicine composition for comprehensively treating diabetes and complications thereof |
| CN106511442A (en) * | 2016-12-21 | 2017-03-22 | 河南爱因糖尿病健康科学研究院股份有限公司 | Inonotus obliquus compound tablet candy with function of reducing blood sugar and preparation method thereof |
| CN107114761A (en) * | 2017-06-13 | 2017-09-01 | 通化康元生物科技有限公司 | Inonotus obliquus ginseng sealwort piece |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101160943B1 (en) | Health functional foods compositions for the prevention and amelioration of cancer containing the mixed extract of Phellinus linteus mycelium and cultured Panax Ginseng Cameyer as an active ingredient | |
| CN103493941B (en) | A kind of Weight-reducing health-care tea and preparation method thereof | |
| CN102526478B (en) | Formula of health-care medicine with functions of strengthening immunity and reducing blood sugar | |
| CN101579120A (en) | Nutritional food with weight-losing function and preparation method thereof | |
| CN1452875A (en) | Health tea with rhodiola root and glossy ganoderma as main material and its making process | |
| CN103169793B (en) | Medicine for treating hypertension, hyperlipoidemia and diabetes mellitus | |
| CN112546167A (en) | Traditional Chinese medicine composition with spleen invigorating and dampness removing functions and preparation method and application thereof | |
| CN107853517B (en) | Traditional Chinese medicine beverage capable of refreshing and resisting fatigue and preparation method thereof | |
| CN108576346A (en) | A kind of Inonotus obliquus pressed candy of energy anticancer reducing pressure and sugar reducing blood lipid | |
| CN101711840B (en) | Medicine-food dual-purpose composition suitable for cancerous patients and preparation method thereof | |
| CN105999096A (en) | Composition for enhancing immunity and application | |
| CN116370556A (en) | Traditional Chinese medicine composition for promoting blood circulation to remove blood stasis, tonifying qi and soothing nerves and preparation method thereof | |
| CN112754013A (en) | Green money poria cocos health-care particles and preparation method thereof | |
| CN108244323A (en) | A kind of Inonotus obliquus pressed candy of energy anticancer reducing pressure and sugar prevention cerebral thrombus | |
| CN101248877A (en) | Anti-aging functional food and preparation method thereof | |
| CN103815482A (en) | Hairyvein agrimony beverage | |
| CN104256821B (en) | A kind of agate coffee compound oral liquid and preparation method thereof | |
| CN112402569A (en) | Anti-fatigue health product and preparation method thereof | |
| CN103181557A (en) | Nutritious food with slimming function and preparation method thereof | |
| CN108477372A (en) | A kind of Inonotus obliquus pressed candy of energy anticancer reducing pressure and sugar anti-aging tranquilizing effect | |
| CN101259156A (en) | Arenaria kansuensis solid state formulation and preparation thereof | |
| CN110584037A (en) | Food ginseng cream and preparation method thereof | |
| CN106421665B (en) | A kind of compound traditional Chinese medicine composite improves the immunity of the human body the application in drug in preparation | |
| CN104757180A (en) | Traditional Chinese medicinal health tea drink containing codonopsis pilosula and radix ophiopogonis and preparation method of tea drink | |
| CN104206939A (en) | Kidney-tonifying tortoise herb jelly |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180706 |